Plain-English translation of NCT07348341 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a registry study — a careful tracking system — for people undergoing a heart procedure that uses a laser tool called ELCA to help clear calcium buildup and blockages in heart arteries. Researchers want to understand how safe and effective this laser tool is when used during standard heart catheterization procedures, and how it affects patient outcomes over one year.
Some coronary artery blockages are difficult to treat with standard balloon catheters, especially when there is significant calcium buildup. This study aims to collect real-world data on how well the laser tool works in these challenging cases and whether it improves the safety and success of the overall procedure.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will have the laser procedure as part of your scheduled heart catheterization — this is standard treatment your doctor already planned. You will then have follow-up visits and assessments on the day of discharge, at 1 month, and at 1 year to check how you are doing. The study simply tracks your outcomes and safety over this year-long period as you receive usual hospital care.
AI-generated summary from trial data · Aug 12, 2026 · Not medical advice
Spain
Sponsor
Ceric Sàrl
Collaborators
Philips Medical Systems, European Cardiovascular Research Center
Enrollment target
~500 participants
Started
July 2026
Primary completion
July 2028
Age range
18 Years and older
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Julie FAURE
Dorset Heart Centre, The Royal Bournemouth Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.